Article and Video CATEGORIES

Cancer Journey

Search By

Sandip Patel, MD, is a board-certified medical oncologist who specializes in cancer immunotherapy and early phase clinical trials involving immunotherapy across all types of cancer. Dr. Patel is focused on developing personalized therapies that stimulate a patient’s immune system to attack their specific tumor. He believes in offering these promising immunotherapeutics across all tumor types. 

Targeted Therapies Forum Presented in English 2023 - Q&A Video Series 2
AlexandraGBeneke
Our Targeted Therapies Forum online event includes a Q&A session where our amazing faculty answers questions from the audience. This is the second batch of videos for our Q&A session.
Author
Sandip P. Patel, MD, GRACE Faculty
Image
Targeted Therapies Forum presented in English

In this series of videos from the Q&A sessions, the following videos are available for viewing:

  • Q&A: Should Biomarker Testing Be Performed on Patients with Squamous Cell Carcinoma?
  • Resistance on Targeted Therapy: Questions Patients Should Ask
  • What Are Some Local Therapy Options for Patients with NSCLC?
  • Q&A: What Can Patients Do to Close the Biomarker Testing Gap?
  • Q&A: What Do We Know About Prevention and Causes of Lung Cancer?

To watch the complete playlist click here.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Online Community

An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:

  1. The antibody, which serves as the “horse,” specifically targets a protein found on cancer...

Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...

The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)

There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...

Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.

The...

Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...

Hi Stan!  So good to hear from you.  I'm sorry for the late response.  I too have been out of town with family and missed your post, probably because I was...

It is so good to hear from you!  And I am so happy to hear that your holidays have been good and that you are doing well.  It sounds like your...

Recent Comments

JOIN THE CONVERSATION
Biomarkers
By JanineT GRACE … on
Radiation Therapy
By JanineT GRACE … on
Oligometastatic vs Oligoprogression
By JanineT GRACE … on
Hi Stan!! and happiest of holidays!
By dbrock on